You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR CERDELGA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for CERDELGA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02536755 ↗ Study of Skeletal Response to Eliglustat in Patients With Gaucher Disease Completed Genzyme, a Sanofi Company Phase 3 2015-10-28 Primary Objective: Evaluate long term skeletal response to eliglustat in adult patients who successfully completed one of the Phase 2 or Phase 3 eliglustat studies. Secondary Objective: Evaluate the safety of eliglustat (by [serious] adverse event [AE] continuous monitoring), the quality of life (Short Form-36 Health Survey [SF-36]) and biomarkers of Gaucher disease type 1 (GD1) (chitotriosidase, plasma glucosylceramide [GL-1] and lyso glucosylceramide [lyso-GL-1]) in adult patients who successfully completed one of the Phase 2 or Phase 3 studies.
NCT03485677 ↗ Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3 Recruiting Sanofi Phase 3 2018-04-11 Primary Objective: Evaluate the safety and pharmacokinetics of eliglustat in pediatric patients (≥2 to <18 years old). Secondary Objective: Evaluate the efficacy of eliglustat and quality of life in pediatric patients (≥2 to <18 years old).
NCT03519646 ↗ Eliglustat on Gaucher Disease Type IIIB Unknown status Sanofi N/A 2018-04-23 Evaluation of the safety in the combination usage of Cerdelga and Cerezyme in type III Gaucher disease patients and the efficacy on soft tissue diseases.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for CERDELGA

Condition Name

Condition Name for CERDELGA
Intervention Trials
Gaucher's Disease 3
Gaucher's Disease Type I 2
Gaucher's Disease Type III 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for CERDELGA
Intervention Trials
Gaucher Disease 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for CERDELGA

Trials by Country

Trials by Country for CERDELGA
Location Trials
Russian Federation 2
Canada 2
United States 2
France 1
Spain 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for CERDELGA
Location Trials
Indiana 1
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for CERDELGA

Clinical Trial Phase

Clinical Trial Phase for CERDELGA
Clinical Trial Phase Trials
Phase 3 2
Phase 1 3
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for CERDELGA
Clinical Trial Phase Trials
Completed 4
Recruiting 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CERDELGA

Sponsor Name

Sponsor Name for CERDELGA
Sponsor Trials
Sanofi 5
Genzyme, a Sanofi Company 1
National Taiwan University Hospital 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for CERDELGA
Sponsor Trials
Industry 6
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.